CASI icon

CASI Pharmaceuticals
CASI

22 hedge funds and large institutions have $4.33M invested in CASI Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 5 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

less funds holding

Funds holding: →

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

Holders
22
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$403K
2
+$320K
3
+$55.2K
4
GSC
Ground Swell Capital
South Carolina
+$16.8K
5
Renaissance Technologies
Renaissance Technologies
New York
+$7.8K

Top Sellers

1
-$52.1K
2
-$42.8K
3
-$35.4K
4
TSS
Two Sigma Securities
New York
-$13.7K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$12K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
26
Citigroup
New York
–
1
2